A Double-blind Randomized Comparison of Celecoxib Plus Esomeprazole Versus Naproxen Plus Esomeprazole for Prevention of Recurrent Ulcer Bleeding in Patients With Arthritis and Cardiothrombotic Diseases (NSAID#8 Study)

Trial Profile

A Double-blind Randomized Comparison of Celecoxib Plus Esomeprazole Versus Naproxen Plus Esomeprazole for Prevention of Recurrent Ulcer Bleeding in Patients With Arthritis and Cardiothrombotic Diseases (NSAID#8 Study)

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Aug 2017

At a glance

  • Drugs Celecoxib (Primary) ; Aspirin; Esomeprazole; Naproxen
  • Indications Arthritis; Ischaemic heart disorders; Musculoskeletal pain; NSAID-induced gastric damage; Thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms NSAID-8
  • Most Recent Events

    • 15 Aug 2017 Results published in the Annals of Internal Medicine
    • 30 Dec 2016 Status changed from recruiting to completed.
    • 03 Mar 2013 Planned End Date changed from 1 Jun 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top